A new trading day began on Tuesday, with Pyxis Oncology Inc (NASDAQ: PYXS) stock price up 3.69% from the previous day of trading, before settling in for the closing price of $3.25. PYXS’s price has ranged from $1.35 to $6.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 41.89%. With a float of $47.32 million, this company’s outstanding shares have now reached $58.89 million.
Let’s determine the extent of company efficiency that accounts for 50 employees.
Pyxis Oncology Inc (PYXS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Pyxis Oncology Inc is 19.65%, while institutional ownership is 46.08%. The most recent insider transaction that took place on Sep 28 ’23, was worth 14,960. In this transaction CFO and COO of this company bought 8,000 shares at a rate of $1.87, taking the stock ownership to the 818,532 shares. Before that another transaction happened on Sep 27 ’23, when Company’s CFO and COO bought 6,426 for $1.85, making the entire transaction worth $11,868. This insider now owns 810,532 shares in total.
Pyxis Oncology Inc (PYXS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 41.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.60% during the next five years compared to -118.72% drop over the previous five years of trading.
Pyxis Oncology Inc (NASDAQ: PYXS) Trading Performance Indicators
Here are Pyxis Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.38, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.31 in one year’s time.
Technical Analysis of Pyxis Oncology Inc (PYXS)
Looking closely at Pyxis Oncology Inc (NASDAQ: PYXS), its last 5-days average volume was 0.49 million, which is a drop from its year-to-date volume of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 17.21%. Additionally, its Average True Range was 0.29.
During the past 100 days, Pyxis Oncology Inc’s (PYXS) raw stochastic average was set at 16.62%, which indicates a significant decrease from 25.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.09% in the past 14 days, which was lower than the 82.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.49, while its 200-day Moving Average is $3.46. However, in the short run, Pyxis Oncology Inc’s stock first resistance to watch stands at $3.56. Second resistance stands at $3.76. The third major resistance level sits at $3.96. If the price goes on to break the first support level at $3.16, it is likely to go to the next support level at $2.96. Now, if the price goes above the second support level, the third support stands at $2.76.
Pyxis Oncology Inc (NASDAQ: PYXS) Key Stats
With a market capitalization of 198.46 million, the company has a total of 58,888K Shares Outstanding. Currently, annual sales are 0 K while annual income is -73,790 K. The company’s previous quarter sales were 16,150 K while its latest quarter income was -3,260 K.
